LB7. A Randomized, Blinded, Placebo- and Vancomycin-Controlled, First-In-Human (FIH) Study of the Safety, Pharmacokinetics (PK), and Fecal Microbiome Effects of ACX-362E, a Novel A...

por Garey, Kevin W, Garey, Kevin W, Kankam, Martin, Mercier, Julie, Seng Yue, Corinne, Ducharme, Murray, Gonzales-Luna, Anne J, Gonzales-Luna, Anne J, Jahangir Alam, M, Begum, Khurshida, Begum, Khurshida, Silverman, Michael
Publicado 2019

A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of...

por Garey, Kevin W, Begum, Khurshida, Lancaster, Chris, Gonzales-Luna, Anne, Bui, Dinh, Mercier, Julie, Seng Yue, Corinne, Ducharme, Murray P, Hu, Ming, Vince, Bradley, Silverman, Michael H, Alam, M Jahangir, Kankam, Martin
Publicado 2020

First Human Use of RUC‐4: A Nonactivating Second‐Generation Small‐Molecule Platelet Glycoprotein IIb/IIIa (Integrin αIIbβ3) Inhibitor Designed for Subcutaneous Point‐of‐Care Treatm...

por Kereiakes, Dean J., Henry, Tim D., DeMaria, Anthony N., Bentur, Ohad, Carlson, Marilyn, Seng Yue, Corinne, Martin, Linda H., Midkiff, Jeff, Mueller, Michele, Meek, Terah, Garza, Deborah, Gibson, C. Michael, Coller, Barry S.
Publicado 2020